These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25835433)

  • 1. Antiviral treatment of influenza in South Korea.
    Choe YJ; Lee H; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):741-9. PubMed ID: 25835433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
    Hurt AC; Ho HT; Barr I
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of neuraminidase inhibitor susceptibility in influenza strains.
    Spanakis N; Pitiriga V; Gennimata V; Tsakris A
    Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1325-36. PubMed ID: 25301229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivirals used for influenza chemoprophylaxis.
    Tsiodras S; Nikolopoulos G; Bonovas S
    Curr Med Chem; 2012; 19(35):5947-56. PubMed ID: 22963557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
    Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
    Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance in influenza viruses].
    Hungnes O; Dudman SG
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral drugs for seasonal influenza 2015-2016.
    Med Lett Drugs Ther; 2015 Dec; 57(1484):169-71. PubMed ID: 26670552
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influenza becomes treatable. Breakthrough against the last great epidemic?].
    Einecke D
    MMW Fortschr Med; 1999 Dec; 141(49-50):4-6. PubMed ID: 10726138
    [No Abstract]   [Full Text] [Related]  

  • 13. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.
    Barr IG; Deng YM; Iannello P; Hurt AC; Komadina N
    Antiviral Res; 2008 Nov; 80(2):200-5. PubMed ID: 18611414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivirals and the control of influenza outbreaks.
    Hota S; McGeer A
    Clin Infect Dis; 2007 Nov; 45(10):1362-8. PubMed ID: 17968836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing antiviral therapy for influenza: understanding the evidence.
    Ison MG
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):417-25. PubMed ID: 25695406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral resistance in influenza viruses: laboratory testing.
    Laplante J; St George K
    Clin Lab Med; 2014 Jun; 34(2):387-408. PubMed ID: 24856534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
    Hurt AC; Okomo-Adhiambo M; Gubareva LV
    Methods Mol Biol; 2012; 865():115-25. PubMed ID: 22528156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeted drugs against influenza--how will this affect the epidemics?].
    Pyhälä R; Ziegler T; Lumio J
    Duodecim; 2000; 116(1):13-5. PubMed ID: 11764456
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.